Open AccessSurvival of Patients With Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus
Author(s) -
Sahityasri Thapi,
Kiwoon Joshua Baeg,
Michelle K. Kim,
Emily J. Gallagher
Publication year - 2021
Publication title -
pancreas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.061
H-Index - 104
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/mpa.0000000000001911
Subject(s) - medicine , hazard ratio , gastroenterology , stage (stratigraphy) , diabetes mellitus , confidence interval , neuroendocrine tumors , epidemiology , multivariate analysis , endocrinology , biology , paleontology
Diabetes mellitus (DM) is associated with an increased risk of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), but the association between DM and GEP-NET survival is unknown. We evaluated disease characteristics and survival in individuals with DM and GEP-NETs.